217 POSTER Pre-clinical evaluation of efficacy and PK/PD biomarkers of GDC-0941, a potent class 1 PI3K inhibitor
S. Patel, D. Sampath, M. Belvin, A. Brown, K. Edgar, L. Lensun, P. Moore, L. Salphati, H. Stern, L. FriedmanVolume:
6
Year:
2008
Language:
english
DOI:
10.1016/s1359-6349(08)72149-9
File:
PDF, 57 KB
english, 2008